- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/131 - Amines, e.g. amantadine acyclic
Patent holdings for IPC class A61K 31/131
Total number of patents in this class: 311
10-year publication summary
22
|
22
|
17
|
22
|
28
|
28
|
26
|
22
|
25
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Intellikine LLC | 42 |
7 |
Duke University | 3087 |
5 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
5 |
ThermoLife International, LLC | 128 |
5 |
Acelot, Inc. | 11 |
5 |
Institut Curie | 591 |
4 |
University of Maryland, Baltimore | 1027 |
4 |
The Board of Regents of the University of Texas System | 2215 |
4 |
Centre National de La Recherche Scientifique | 10516 |
3 |
The Johns Hopkins University | 5709 |
3 |
The Trustees of the University of Pennsylvania | 4337 |
3 |
The Board of Trustees of the University of Illinois | 2713 |
3 |
Advanced Biodesign | 20 |
3 |
Aminex Therapeutics, Inc. | 11 |
3 |
BioInteractions, Ltd. | 29 |
3 |
Case Western Reserve University | 1835 |
3 |
Cedars-Sinai Medical Center | 1165 |
3 |
Cornell University | 3329 |
3 |
Dana-Farber Cancer Institute, Inc. | 2585 |
3 |
Kinki University | 245 |
3 |
Other owners | 236 |